SCHEMBL30009195

SCHEMBL30009195

O=C(c1cccc(O)c1)c1cc2c(ccc3ccccc32)[nH]1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 2/20 0.66
DYRK1A Q13627 2/20 0.66
KDM4E B2RXH2 2/20 0.62
ALDH1A1 P00352 2/20 0.62
LMNA P02545 2/20 0.62
HSD17B10 Q99714 1/20 0.62
FLT3 P36888 9/20 0.50
PDGFRB P09619 3/20 0.50
PDGFRA P16234 1/20 0.50
KIT P10721 2/20 0.49
DYRK1B Q9Y463 1/20 0.48
ABL1 P00519 1/20 0.45
BCR P11274 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CDK4 P11802 1/20 0.44
CCND1 P24385 1/20 0.44
HTR6 P50406 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14739483 1.00 CLK1 (0.66) CLK1DYRK1AKDM4EALDH1A1LMNA
SCHEMBL12428146 0.88 HSD17B10 (0.74) CLK1DYRK1AKDM4EALDH1A1LMNA
SCHEMBL30116222 0.87 KDM4E (0.64) CLK1DYRK1AKDM4EALDH1A1LMNA
SCHEMBL14739175 0.87 KDM4E (0.64) CLK1DYRK1AKDM4EALDH1A1LMNA
SCHEMBL12427250 0.85 ALDH1A1 (0.61) CLK1DYRK1AKDM4EALDH1A1LMNA
SCHEMBL2302083 0.84 KDM4E (0.57) CLK1DYRK1AKDM4EALDH1A1LMNA
SCHEMBL29402473 0.84 KDM4E (0.57) CLK1DYRK1AKDM4EALDH1A1LMNA
SCHEMBL29402366 0.83 MEN1 (0.62) KDM4EALDH1A1LMNAHSD17B10FLT3
SCHEMBL14739487 0.83 MEN1 (0.62) KDM4EALDH1A1LMNAHSD17B10FLT3
SCHEMBL14740027 0.82 ALDH1A1 (0.73) CLK1DYRK1AKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4340897-A1 METHODS AND COMPOSITIONS FOR TREATING PANCREATIC AND HEPATIC DISEASE METANOIA BIO INC. (US) 2024-03-27 EP disclosed
EP-4340896-A1 METHODS AND COMPOSITIONS FOR TREATING OCULAR NEOVASCULAR DISEASE METANOIA BIO INC. (US) 2024-03-27 EP disclosed
CN-116615241-A Methods and compositions for diabetes treatment and beta cell regeneration 加利福尼亚大学董事会 2023-08-18 CN disclosed
WO-2022245698-A1 METHODS AND COMPOSITIONS FOR TREATING PANCREATIC AND HEPATIC DISEASE METANOIA BIO INC. (US) 2022-11-24 WO disclosed
WO-2022245697-A1 METHODS AND COMPOSITIONS FOR TREATING OCULAR NEOVASCULAR DISEASE METANOIA BIO INC. (US) 2022-11-24 WO disclosed